Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: Prospective, enhanced, national population-based surveillance

Clinical Infectious Diseases

Volumn 59, Issue 10, 2014, Pages e150-e157

  Okike, Ifeanyichukwu O ^a,b   Johnson, Alan P ^b   Henderson, Katherine L ^b   Blackburn, Ruth M ^b   Muller Pebody, Berit ^b   Ladhani, Shamez N ^a,c   Anthony, Mark ^d   Ninis, Nelly ^e   Heath, Paul T ^a   Galiza, Eva P ^a   Cameron, J Claire ^f   Smith Palmer, Alison ^f   McDonald, Eisin ^f   Sinka, Katy ^f   Jones, Laura ^g   Cunney, Robert ^h   Borgulya, Gabor ^a   Borrow, Ray ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Healthcare Assocd Infections and Antimicrobial Resistance Department   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f HEALTH PROTECTION SCOTLAND   (United Kingdom)

^g ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^h HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

Author keywords

Bacterial; BPSU; Meningitis; Neonatal; Surveillance

Indexed keywords

ARTICLE; BACTERIAL MENINGITIS; DISEASE SURVEILLANCE; ESCHERICHIA COLI; FEMALE; GRAM POSITIVE BACTERIUM; GROUP B STREPTOCOCCAL MENINGITIS; HUMAN; INCIDENCE; INFANT; INFANT DISEASE; IRELAND; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; OUTCOME ASSESSMENT; PNEUMOCOCCAL MENINGITIS; PREMATURITY; PROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; UNITED KINGDOM; HEALTH SURVEY; MENINGITIS, BACTERIAL; MICROBIOLOGY; NEWBORN; RISK FACTOR;

FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; IRELAND; MALE; MENINGITIS, BACTERIAL; MORTALITY; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84908319248     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu514     Document Type: Article

References (30)

1. Okike IO, Ribeiro S, Ramsay ME, Heath PT, Sharland M, Ladhani S. Trends in bacterial, mycobacterial and fungal meningitis in England and Wales during 2004-2011: an observational study. Lancet Infect Dis 2014;14:301-7.
2. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011;364:2016-25.
3. De Louvois J, Halket S, Harvey D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr 2005;164:730-4.
4. De Louvois J, Blackbourn J, Hurley R, Harvey D. Infantile meningitis in England and Wales: a two year study. Arch Dis Child 1991;66:603-7.
5. Holt DE, Halket S, De Louvois J, Harvey D. Neonatal meningitis in England and Wales: 10 years on. Arch Dis Child Fetal Neonatal Ed 2001;84:F85-9.
6. Mulder CJ, Zanen HC. A study of 280 cases of neonatal meningitis in the Netherlands. J Infect 1984;9:177-84.
7. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 2009;28(1 suppl):S3-9.
8. Heath PT, Okike IO, Oeser C. Neonatal meningitis: can we do better? Adv Exp Med Biol 2011;719:11-24.
9. Gaschignard J, Levy C, Romain O, et al. Neonatal bacterial meningitis: 444 cases in 7 years. Pediatr Infect Dis J 2011;30:212-7.
10. Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012;130:e8-15.
11. Hughes R, Brocklehurst P, Heath PT, Stenson B. Prevention of neonatal early onset group B streptococcal disease. Guideline no. 36, 1-10. London: Royal College of Obstetrics and Gynaecology, 2003.
12. Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol 2010;17:840-7.
13. Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales. Clin Infect Dis 2013;56:633-40.
14. Verity C, Preece M. Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit. Arch Dis Child 2002;87:269-71.
15. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009;64(suppl 1):i11-7.
16. Health Protection Scotland. Laboratory surveillance in Scotland. Available at: http://www.hps.scot.nhs.uk/surveillance/SystemsDetail.aspx?id=248. Accessed 26 June 2014.
17. Health Protection Surveillance Centre. Laboratory surveillance in the Republic of Ireland. Available at: http://www.hpsc.ie/hpsc/CIDR. Accessed 26 June 2014.
18. Garges HP, Moody MA, Cotten CM, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics 2006;117:1094-100.
19. Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics 2010;125:257-64.
20. Greenberg RG, Smith PB, Cotten CM, Moody MA, Clark RH, Benjamin DK Jr. Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count. Pediatr Infect Dis J 2008;27:1047-51.
21. Office for National Statistics. Live-birth data for the United Kingdom, 2010. Available at: http://www.ons.gov. uk. Accessed 26 June 2014.
22. Central Statistics Office. Live-birth data for the Republic of Ireland, 2010. Available at: http://www.cso.ie. Accessed 26 June 2014.
23. Health and Social Care Information Centre. Hospital Episodes Statistics for England. Available at: http://www.ic.nhs.uk. Accessed 26 June 2014.
24. Davies PA, Rudd P. Neonatal meningitis. In: Clinics in developmental medicine. London: MacKeith Press, 1994.
25. Trijbels-Smeulders M, De Jonge GA, Pasker-De Jong PC, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed 2007;92:F271-6.
26. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292-4.
27. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59(RR-10):1-36.
28. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev 2009;6: CD007467.
29. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011;29:9127-31.
30. Lynn R. British Paediatric Surveillance Unit, 25th annual report 2010-2011. London: British Paediatric Surveillance Unit, 2011.